Actions of two new antagonists showing selectivity for different sub‐types of metabotropic glutamate receptor in the neonatal rat spinal cord
Open Access
- 19 July 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 112 (3), 809-816
- https://doi.org/10.1111/j.1476-5381.1994.tb13151.x
Abstract
1 The presynaptic depressant action of l-2-amino-4-phosphonobutyrate (l-AP4) on the monosynaptic excitation of neonatal rat motoneurones has been differentiated from the similar effects produced by (1S,3R)-1-aminocyclopentane-1,3-dicarboxylate ((1S,3R)-ACPD), (1S,3S)-ACPD and (2S,3S,4S)-α-(carboxycyclopropyl)glycine (l-CCG-I), and from the postsynaptic motoneuronal depolarization produced by (1S,3R)-ACPD, by the actions of two new antagonists, α-methyl-l-AP4 (MAP4) and α-methyl-l-CCG-I (MCCG). Such selectivity was not seen with a previously reported antagonist, (+)-α-methyl-4-carboxyphenylglycine (MCPG). 2 MAP4 selectively and competitively antagonized the depression of monosynaptic excitation produced by l-AP4 (KD 22 μm). At ten fold higher concentrations, MAP4 also antagonized synaptic depression produced by l-CCG-I but in an apparently non-competitive manner. MAP4 was virtually without effect on depression produced by (1S,3R)- or (1S,3S)-ACPD. 3 MCCG differentially antagonized the presynaptic depression produced by the range of agonists used. This antagonist had minimal effect on l-AP4-induced depression. The antagonism of the synaptic depression effected by (1S,3S)-ACPD and l-CCG-I was apparently competitive in each case but of varying effectiveness, with apparent KD values for the interaction between MCCG and the receptors activated by the two depressants calculated as 103 and 259 μm, respectively. MCCG also antagonized the presynaptic depression produced by (1S,3R)-ACPD. 4 Neither MAP4 nor MCCG (200–500 μm) significantly affected motoneuronal depolarizations produced by (1S,3R)-ACPD. At the same concentrations the two antagonists produced only very weak and variable effects (slight antagonism or potentiation) on depolarizations produced by (S)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and N-methyl-d-aspartate (NMDA). 5 It is concluded that MAP4 is a potent and selective antagonist for those excitatory amino acid (EAA) receptors on neonatal rat primary afferent terminals that are preferentially activated by l-AP4, and that MCCG is a relatively selective antagonist for different presynaptic EAA receptors that are preferentially activated by (1S,3S)-ACPD and (perhaps less selectively) by l-CCG-I. These receptors probably comprise two sub-types of metabotropic glutamate receptors negatively linked to adenylyl cyclase activity.Keywords
This publication has 22 references indexed in Scilit:
- Antagonism of presynaptically mediated depressant responses and cyclic AMP-coupled metabotropic glutamate receptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- The actions of phenylglycine derived metabotropic glutamate receptor antagonists on multiple (1S,3R)-ACPD responses in the rat nucleus of the tractus solitariusNeuropharmacology, 1993
- Stereospecific antagonism by (+)-α-methyl-4-carboxyphenylglycine (MCPG) of (1S,3R)-ACPD-induced effects in neonatal rat motoneurones and rat thalamic neuronesNeuropharmacology, 1993
- Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptorsNature, 1993
- Mediation of Thalamic Sensory Responses In Vivo by ACPD‐activated Excitatory Amino Acid ReceptorsEuropean Journal of Neuroscience, 1993
- Metabotropic glutamate receptors in brain function and pathologyTrends in Pharmacological Sciences, 1993
- Competitive antagonism at metabotropic glutamate receptors by (S) -4-carboxyphenylglycine and (RS) -α-methyl-4-carboxyphenylglycineEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- 3,5-DihydroxyphenylglycineNeuroReport, 1992
- Molecular Diversity of Glutamate Receptors and Implications for Brain FunctionScience, 1992
- A family of metabotropic glutamate receptorsNeuron, 1992